P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL

• F. Morschhauser,
• Y. Jiang,
• F. Jardin,
• A. F. Herrera,
• L. H. Sehn,
• C. Herbaux,
• C. Flowers,
• T. Phillips,
• A. López Guillermo,
• C. Diefenbach,
• G. P. Gregory,
• A. Kim,
• A. M. Barbui,
• S. Balasubramanian,
• W. Harris,
• J. Hirata,
• J. N. Paulson,
• C. Lee,
• G. Lenz

Affiliations

F. Morschhauser

1 Lille University Hospital Center, Lille Cedex, France

Y. Jiang

2 Genentech, Inc., South San Francisco, United States of America

F. Jardin

3 University of Rouen, Rouen, France

A. F. Herrera

4 City of Hope, Duarte, United States of America

L. H. Sehn

5 BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, Canada

C. Herbaux

6 University of Montpellier, Montpellier, France

C. Flowers

7 M.D. Anderson Cancer Center, Atlanta

T. Phillips

8 University of Michigan Medical School, Ann Arbor, United States of America

A. López Guillermo

9 Hospital Clínic de Barcelona, Barcelona, Spain

C. Diefenbach

10 Perlmutter Cancer Center at NYU Langone Health, New York, United States of America

G. P. Gregory

11 Clinical Sciences at Monash Health, Monash University, Melbourne, Australia

A. Kim

12 Dana-Farber Cancer Institute, Boston, United States of America

A. M. Barbui

13 Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

S. Balasubramanian

2 Genentech, Inc., South San Francisco, United States of America

W. Harris

2 Genentech, Inc., South San Francisco, United States of America

J. Hirata

2 Genentech, Inc., South San Francisco, United States of America

J. N. Paulson

2 Genentech, Inc., South San Francisco, United States of America

C. Lee

2 Genentech, Inc., South San Francisco, United States of America

G. Lenz

14 University Hospital Münster, Münster, Germany